News for Proteome Sciences plc (PMSNF)

The following stocks are the leading risers and fallers on AIM in London on Thursday. ---------- AIM - WINNERS ---------- Proteome Sciences PLC, up 14% at 3.99 pence, 12-month range 2.65p-8.79p. The...

Proteome Sciences PLC shares plummeted on Thursday, after it cut its revenue outlook for 2023 amid delays to projects. Proteome is a London-based protein-focused drug development services provider....

/PRNewswire/ -- The neurological biomarkers market size is expected to grow by USD 6.92 billion from 2022 to 2027. In addition, the momentum of the market will...

Protein sequencing market is segmented based on the application and technology. Based on application, the protein sequencing market is segmented into...

Proteome Sciences PLC - London-based drug development services provider - Says it has repaid in full its outstanding loan and associated interest, totalling GBP824,424, to Vulpes Investment... | June 1, 2023

Scancell Holdings plc Annual General Meeting of Scancell Holdings plc to be held at ... | October 28, 2022

Read Proteome Sciences (LON:PRM) Shares Pass Above Fifty Day Moving Average of $3.80 at ETF Daily News

Read Proteome Sciences (LON:PRM) Shares Pass Above Fifty Day Moving Average of $3.80 at ETF Daily News

/PRNewswire/ -- The neurological biomarkers market will be driven by factors such as the increasing incidences of neurological disorders. Patients with severe...